TABLE OF CONTENTS SUMMARY 3 CONCLUSIONS AND REGULATORY OBLIGATIONS 3 ASSESSMENT DETAILS 6 1. APPLICANT AND NOTIFICATION DETAILS 6 2. IDENTITY OF CHEMICAL 6 3. COMPOSITION 7 4. PHYSICAL AND CHEMICAL PROPERTIES 7 5. INTRODUCTION AND USE INFORMATION 7 6. HUMAN HEALTH IMPLICATIONS 8 6.1. Exposure Assessment 8 6.1.1. Occupational Exposure 8 6.1.2. Public Exposure 9 6.2. Human Health Effects Assessment 9 6.3. Human Health Risk Characterisation 10 6.3.1. Occupational Health and Safety 10 6.3.2. Public Health 11 7. ENVIRONMENTAL IMPLICATIONS 11 7.1. Environmental Exposure & Fate Assessment 11 7.1.1. Environmental Exposure 11 7.1.2. Environmental Fate 12 7.1.3. Predicted Environmental Concentration (PEC) 12 7.2. Environmental Effects Assessment 13 7.2.1. Predicted No-Effect Concentration 13 7.3. Environmental Risk Assessment 13 Appendix A: Physical and Chemical Properties 14 Appendix B: Toxicological Investigations 16 B.1. Acute toxicity – oral 16 B.2. Acute toxicity – dermal 16 B.3. Acute toxicity – inhalation 17 B.4. Irritation – skin (in vitro) 17 B.5. Irritation – skin 18 B.6. Irritation – eye (in vitro) 18 B.7. Irritation – eye 19 B.8. Skin sensitisation – mouse local lymph node assay (LLNA) 19 B.9. Skin sensitisation – human volunteers 20 B.10. Repeat dose toxicity 20 B.11. Genotoxicity – bacteria 21 B.12. Genotoxicity – in vitro 22 Appendix C: Environmental Fate and Ecotoxicological Investigations 24 C.1. Environmental Fate 24 C.1.1. Ready biodegradability 24 C.2. Ecotoxicological Investigations 24 C.2.1. Acute toxicity to fish 24 C.2.2. Acute toxicity to aquatic invertebrates 25 C.2.3. Algal growth inhibition test 26 C.2.4. Inhibition of microbial activity 26 BIBLIOGRAPHY 28
Harlan (2015) [Product Mixture Containing Notified Chemical]: Determination of Skin Irritation Potential using the EPISKIN Reconstructed Human Epidermis Model (Study No. 41304368, April, 2015). Shardlow, Derbyshire, UK, Harlan Laboratories Ltd (Unpublished report submitted by the notifier). HLS (2014a) [Product Mixture Containing Notified Chemical]: Toxicity Study by Oral Administration to CD Rats for 4 Weeks Followed by a 2 Week Recovery Period (Study No. HIK0037, December, 2014). Huntingdon, Cambridgeshire, UK, Huntingdon Life Sciences (Unpublished report submitted by the notifier). HLS (2014b) [Product Mixture Containing Notified Chemical]: Activated Sludge: Respiration Inhibition Test (HLS study number: HIK0038, June 2014). Suffolk, UK, Huntingdon Life Sciences (Unpublished report submitted by the notifier). HLS (2015a) [Product Mixture Containing Notified Chemical]: Acute Toxicity to Daphnia magna (OECD 202) (HLS study number: IHIK0040, June, 2015). Suffolk, UK, Huntingdon Life Sciences (Unpublished report submitted by the notifier). HLS (2015b) [Product Mixture Containing Notified Chemical]: Algal Growth Inhibition Assay (HLS study number: HIK0039, April, 2015). Suffolk, UK, Huntingdon Life Sciences (Unpublished report submitted by the notifier). HRL (2015) Final Report – Repeated Insult Patch Test (RIPT) (Study No. 15-105, April, 2015). Union, NJ, USA, Harrison Research Laboratories Inc (Unpublished report submitted by the notifier). NOHSC (2004) Approved Criteria for Classifying Hazardous Substances, 3rd edition [NOHSC:1008(2004)]. National Occupational Health and Safety Commission, Canberra, AusInfo. RIVM (2010) Observations on the Methodology for Quantitative Risk Assessment of Dermal Allergens, Report 320015003/2010, National Institute for Public Health and the Environment. United Nations (2009) Globally Harmonised System of Classification and Labelling of Chemicals (GHS), 3rd revised edition. United Nations Economic Commission for Europe (UN/ECE), <http://www.unece.org/trans/danger/publi/ghs/ghs_rev03/03files_e.html >.